Eight programs. One service underneath all of them.
Each runs on the same eleven SYNC-PREVENT™ points of contact and the same physician oversight. Pick the conditions that fit your population.
Heart Failure Prevention
Closing the gap before hospitalization.
Heart failure is the most expensive — and most preventable — catastrophic event in chronic disease care. The physiologic signals that precede a hospitalization are measurable non-invasively, months before symptoms appear. Standard care usually doesn't look for them until a patient is already symptomatic.
The protocol turns that evidence into a four-step pathway: interoperability-driven risk identification from existing EMR data, biomarker context, non-invasive LVEDP screening with the Vivio device, and continuous at-home monitoring for confirmed cases — each step triggered automatically by the last, with alerts escalated to the ordering physician when readings cross clinical thresholds.
Illustrative model, pending published validation: across a typical 1,000-patient panel, the program is built to prevent a meaningful share of HF admissions — and the avoidable cost that comes with them — within a CMS-reimbursable, physician-led framework.
Continuous Glucose Monitoring
The low gets caught before it arrives.
For an insulin-dependent patient, the dangerous moment is almost never the appointment. It's the overnight low no one sees coming — the one that ends in an ambulance instead of a snack and a dose adjustment.
Insulin-dependent patients 50 and older wear a Dexcom G7, which reports a reading every five minutes and can warn of a falling trend up to twenty minutes before the low actually hits. That warning is the difference between a correction at home and a hospital visit.
The device is half the program. Enrolled patients also work with registered dietitian nutritionists and certified diabetes care and education specialists, so the glucose data turns into changed habits — not just a fuller chart.
Read the full briefPrecision CCM
Chronic care management rebuilt around what actually prevents an episode.
Most CCM programs run on a script — a generic monthly call, a handful of standard questions, and a note that says the call happened. Synchronize Health's CCM program works differently.
Patients enrolled in Precision CCM are supported by credentialed specialists — a pharmacy technician, certified diabetes educator, and registered dietitian nutritionist — each AI-assisted. Before each call, the AI reviews that specific patient's recent labs, device readings, and medication changes, and tells the specialist exactly what's worth asking about this week.
Most monitoring vendors hand you data. This program hands the physician interpreted findings, a nutrition plan the patient will actually sustain, medication reconciliation, and behavioral follow-through — together, not in separate silos.
A new prescription gets checked for early side effects before it causes a complication.
A pattern of overnight glucose lows gets caught before it becomes a severe event.
A few pounds of fluid weight gets addressed before it becomes a hospital admission.
Zero DFU
Preventing amputations before they begin.
One in five Medicare beneficiaries with diabetes has undiagnosed peripheral artery disease — and 85% of amputations start as an untreated diabetic foot ulcer. This is one of the most preventable causes of limb loss in Medicare care.
The Zero DFU Program screens for the vascular problem before the wound forms. Every practice receives rapid ABI/TBI PAD screening with the MESI mTABLET, and at-risk patients take home a connected Bluedrop foot-temperature monitor — a sustained deviation of 2.2°C or more triggers an automatic alert, with confirmed risk routed straight to a wound care or vascular specialist, two to four weeks before anything is visible on the skin.
PAD and DFU screening is a front door: patients identified this way frequently carry overlapping cardiovascular, renal, and metabolic risk, and move naturally into broader Clinical Status Monitoring.
Ostomy S.O.A.P.
Closing the gap between hospital and home.
Nearly 38% of ostomy patients return to the ER or are readmitted within 90 days of surgery — one of the highest readmission rates of any surgical population, driven largely by dehydration and preventable skin complications.
S.O.A.P. closes that gap. Patients enrolled in the program are supported by certified ostomy care nurses, registered dietitians, and physical therapists who bridge hospital and home health care directly — reviewing stoma photos in real time to catch skin problems before they become an ER visit, guiding dietary changes, and supporting structured exercise to reduce parastomal hernia risk.
Read the full briefRespiratory RPM/CCM
Fixing the inhaler technique problem no one is watching.
Up to 60% of patients with asthma or COPD use their inhaler incorrectly — and improper technique alone drives as much as 70% of the total healthcare cost of managing these conditions. Nothing in standard care actually measures how an inhaler is being used.
The CapMedic MDI device tracks the specifics that matter at every single use — date and time, shake duration, inhaler orientation, and inhalation technique. For enrolled patients, that data becomes personalized feedback, not generic reminders, while missed doses are flagged for timely outreach.
The device doubles as a spirometer, giving physicians objective lung function data to track disease progression and adjust treatment.
Read the full briefRA Grip Strength Monitoring
An objective number for a disease that resists measurement.
Rheumatoid arthritis activity is usually judged by how the patient says their hands feel that day — a real answer, but not one a physician can trend. Grip strength gives them a number instead.
Patients measure weekly at home with a Bluetooth-connected dynamometer, following one standardized protocol every time. A declining trend flags disease activity early, before the next scheduled rheumatology visit; a stable or improving one confirms the current treatment is doing its job. Either way, the physician sees the trajectory — not a snapshot filtered through memory.
Read the full briefPost-TAVR
Closing the post-TAVR care gap.
TAVR has transformed the treatment of aortic stenosis — procedural success rates are high and early mortality has declined significantly. But procedural success doesn't guarantee post-discharge success.
The valve gets fixed. The patient doesn't automatically become invisible to risk. Every TAVR patient transitions into continuous Clinical Status Monitoring at discharge — hemodynamic monitoring with Vivio, arrhythmia surveillance through an ECG patch followed by Kardia, heart failure detection through weight/BP/heart rate/SpO₂ trends, and continuous infection surveillance running from discharge through day 90.
Infection surveillance doesn't rely on temperature monitoring alone. The program watches the broader inflammatory and hematologic picture — the signals that precede a fever, not just the fever itself.
Close your blind spot.
Thirty minutes. We'll show you what you're missing between visits.
Talk to Our Team